Researchers investigate the potential link between the obesity drugs semaglutide and liraglutide and suicidal or self-injurious adverse drug reactions.
Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer
MADRID — Treatment with tisotumab vedotin (Tivdak) significantly extended overall survival (OS) compared with chemotherapy in patients with recurrent or metastatic cervical cancer, the phase